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Dopamine is an important neurotransmitter in the central nervous system of vertebrates and in-
vertebrates. Despite their evolutionary distance, striking parallels exist between deuterostomian and
protostomian dopaminergic systems. In both, signalling is achieved via a complement of functionally
distinct dopamine receptors. In this study, we investigated the sequence, pharmacology and tissue
distribution of a D2-like dopamine receptor from the red flour beetle Tribolium castaneum (TricaDop3)
and compared it with related G protein-coupled receptors in other invertebrate species.
The TricaDop3 receptor-encoding cDNA shows considerable sequence similarity with members of the
Dop3 receptor class. Real time qRT-PCR showed high expression in both the central brain and the optic
lobes, consistent with the role of dopamine as neurotransmitter. Activation of TricaDop3 expressed in
mammalian cells increased intracellular Ca2þ signalling and decreased NKH-477 (a forskolin analogue)-
stimulated cyclic AMP levels in a dose-dependent manner. We studied the pharmacological profile of the
TricaDop3 receptor and demonstrated that the synthetic vertebrate dopamine receptor agonists, 2 e
amino- 6,7 e dihydroxy e 1,2,3,4 e tetrahydronaphthalene hydrobromide (6,7-ADTN) and bromocrip-
tine acted as agonists. Methysergide was the most potent of the antagonists tested and showed
competitive inhibition in the presence of dopamine. This study offers important information on the Dop3
receptor from Tribolium castaneum that will facilitate functional analyses of dopamine receptors in in-
sects and other invertebrates.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
The biogenic amine dopamine (DA) is an important neuro-
transmitter both in vertebrates and in invertebrates. DA is impli-
cated in many functions including locomotion, cognition and
development. Furthermore, abnormalities in DA signalling are
believed to play a role in a number of human disorders, such as
schizophrenia, Parkinson's disease, Tourette's syndrome, bipolar
disorder, Huntington's disease, attention deficit hyperactivity dis-
order (ADHD) and drug addiction (Andre et al., 2010; Ares-Santos
et al., 2013; Buse et al., 2013; Cousins et al., 2009; Emsley et al.,sestraat 59 box 2465, 3000
3902.
(H. Verlinden).2013; Gazewood et al., 2013; Wu et al., 2012). In vertebrates, five
distinct G protein-coupled DA receptors mediate all known func-
tions of DA. They can be divided in twomajor groups based on their
structural, pharmacological and biochemical properties: D1-class
DA receptors (D1 and D5, which may also be referred to as D1A
and D1B since they are presumably closely related paralogues that
arose from a gene duplication event) and D2-class DA receptors
(D2, D3 and D4) (Beaulieu & Gainetdinov, 2011; Callier et al., 2003;
Cardinaud et al., 1998).
Because DA is critically involved in a number of physiological
processes, the mode of action, in vivo function and regulation of
vertebrate DA receptors have been extensively studied (Strange,
2005). However, much less is known about invertebrate DA re-
ceptors. Because of the conservation of common functional
properties, the three types of DA receptors typically found in
invertebrates are generally categorised according to the classifi-
cation system used for vertebrate DA receptors. Members of the
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meDop1/dDA1 and ApimeDop1, are closely related to the verte-
brate D1 class of receptors. Members of the Dop2/INDR
(invertebrate specific dopamine receptors) group, which includes
DAMB/DopR99B and ApimeDop2, also show more sequence
similarity with D1-like receptors than with D2-like receptors.
However, the Dop3 class, which includes DromeDD2 and Apime-
Dop3, are more closely related to the vertebrate D2 class of
dopamine receptors (Barbas et al., 2006; Beggs et al., 2011;
McDonald et al., 2006; Meyer et al., 2011; Missale et al., 1998;
Mitsumasu et al., 2008; Mustard et al., 2005). Dop1 and Dop2
are functionally D1-like and activate adenylyl cyclase (Blenau
et al., 1998; Humphries et al., 2003; Mustard et al., 2003). In
contrast, Dop3 are functionally D2-like in that they inhibit ade-
nylyl cyclase (Beggs and Mercer, 2009; Beggs et al., 2005; Hearn
et al., 2002). An additional receptor that interacts with both DA
and ecdysone has been characterised in Drosophila melanogaster.
However, this receptor is not closely related to the other dopa-
mine receptors and will not be further discussed (Evans et al.,
2014; Srivastava et al., 2005).
Nevertheless, multiple indications exist that this traditional
view of DA receptor signalling is much too simple (as also discussed
in Beggs et al., 2005; Clark and Baro, 2007). More and more proof is
provided concerning the signalling complexity of GPCRs in general
and of DA receptors specifically. GPCRs, including DA receptors, can
switch G protein coupling over time in response to constant agonist
application, both the Ga and Gbg subunits are known to elicit in-
dividual responses and G proteins can directly act with target
proteins. Moreover also G protein independent cascades, for
example b-arrestin, influence the cellular response (the reader is
referred to Clark and Baro, 2007; Verlinden et al., 2014 and refer-
ences herein).
In 2011, Beggs and co-workers compared the pharmacological
properties of some Apis mellifera dopamine and octopamine/
tyramine receptors (Beggs et al., 2011). Their data were supported
by phylogenetic analyses (Balfanz et al., 2005; Hauser et al., 2006,
2008; Humphries et al., 2003; Mustard et al., 2003, 2005) indi-
cating that some of the DA and octopamine receptor genes are
paralogues. The most recent classification has grouped insect/
invertebrate octopamine receptors into three classes: a-adren-
ergic-like octopamine receptors (OctaR), b-adrenergic-like
octopamine receptors (OctbR) and octopamine/tyramine or
tyramine receptors (TyrRI and TyrRII) (Bayliss et al., 2013; Evans
and Maqueira, 2005; Verlinden et al., 2010). Dop1 receptors share
pharmacological similarities with OctbR and like OctbR, activa-
tion of Dop1 receptors causes an increase in intracellular cAMP
levels (Blenau et al., 1998; Gotzes et al., 1994; Mitsumasu et al.,
2008; Mustard et al., 2003; Sanyal et al., 2004; Sugamori et al.,
1995). Dop2 receptors are pharmacologically most similar to
OctaR and like OctaR, activation of Dop2 receptors causes an
increase in both intracellular cAMP and intracellular calcium
levels (Beggs et al., 2011; Feng et al., 1996; Gerber et al., 2006;
Han et al., 1996; Humphries et al., 2003; Mitsumasu et al.,
2008; Mustard et al., 2003; Troppmann et al., 2014). Dop3 re-
ceptors on the other hand, are functionally similar to TyrRI. Like
TyrRI, activation of Dop3 receptors has been shown to reduce
intracellular cAMP levels (Beggs et al., 2005; Hearn et al., 2002;
Suo et al., 2003).
In this study, we analyse the properties of a Dop3 receptor
(TricaDop3) from the red flour beetle Tribolium castaneum and
demonstrate that this receptor displays dual coupling characteris-
tics. Like TyrRI (Robb et al., 1994; Reale et al., 1997b; Poels et al.,
2001), TricaDop3 can elicit a rise in intracellular calcium ion
levels, in addition to causing a decrease in intracellular levels of
cAMP.2. Experimental procedures
2.1. Animal rearing conditions and dissections
Beetles were reared in a dark incubator at 30 C on wheat flour
and brewer's yeast in Petri dishes of 140 mm diameter. Adult
beetles were sexed based on the presence of a small patch of short
bristles on the inside of the first pair of legs in males, according to
the Tribolium castaneum rearing protocol (http://bru.gmprc.ksu.
edu/proj/tribolium/wrangle.asp) (Beeman et al., 2009).
The different body parts/tissues (head, gut, fat body, gonads,
accessory glands, brain, optical lobes, salivary glands) were
collected during dissections performed on agar plates (40 g/l) in
Phosphate Buffered Saline (PBS) (NaCl 137 mM, KCl 2.7 mM,
Na2HPO4 10 mM, KH2PO4 1.76 mM; pH 7.2) under a binocular mi-
croscope and snap frozen in liquid nitrogen.
2.2. mRNA isolation and cDNA synthesis
For all samples, tissues of at least fifteen animals were pooled.
Tissues were homogenised and RNA was extracted using the
RNAqueous Micro Kit (Ambion) according to the protocol recom-
mended by the manufacturer. The protocol included an additional
DNase treatment to digest remaining DNA. Concentrations and RNA
purity were determined with a NanoDrop ND1000 spectropho-
tometer (NanoDrop Technologies). Total RNA (150 ng) was reverse
transcribed into cDNA using SuperScriptIII reverse transcriptase
(Invitrogen) as recommended by the manufacturer, and diluted
ten-fold prior to use.
2.3. Cloning of TricaDop3 and construction of pcTricaDop3
expression vector
The full length sequence encoding the receptor was amplified
with PCR using 2 ml whole body T. castaneum cDNA (see x 2.2), Taq
polymerase (REDTaq®ReadyMix™PCR Reaction Mix,
SigmaeAldrich), and 10 mM of sense primer 50-CACCATGATCCCT-
GAAAAAATGGACGC-30 and antisense primer 50-TTAAGGCCCGAG-
GAACATTAA-30 (SigmaeAldrich). Primers were designed based on
sequences available in Beetlebase (Tcas_3.0; http://www.beetlebase.
org/) (Kim et al., 2010) released by the Human Genome Sequencing
Center (GenBank Accession Number EFA02832). PCR started with
initial denaturation for 2min at 95 C, followed by 35 cycles of 30 s at
94 C, 30 s at 62 C and2min at 72 C, followedbyfinal elongation for
5 min at 72 C. Amplification products were run on a 1% agarose gel
and purifiedwith theGenElute™Gel extractionKit (SigmaeAldrich).
The DNA fragment was cloned into a pcDNA3.1D/V5-His-TOPO®
expressionvectorviaTOPOcloning (Invitrogen) and transformed into
One Shot TOP10 chemically competent Escherichia coli cells (Invi-
trogen). Bacteria were grown according to the protocol recom-
mended by the kit. Plasmids were isolated via the GenElute™ HP
Plasmid Miniprep kit (SigmaeAldrich) and DNA sequences were
determined by means of the ABI PRISM 3130 Genetic Analyser
(Applied Biosystems) following the protocol outlined in the ABI
PRISM BigDye Terminator Ready Reaction Cycle Sequencing Kit
(Applied Biosystems). Bacterial cells known to contain the correct
receptor insert were grown at large scale in 100 ml LuriaeBertani
broth medium. The expression vectors were subsequently isolated
from these cells using the EndoFree Plasmid Maxi Kit (Qiagen) ac-
cording to the protocol recommended by the manufacturer.
2.4. Multiple sequence alignment
Amino acid sequences of the Dop3 of the fruit fly and honey bee,
used for the sequence alignment, were identified in the protein
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with MAFFT (LeINSei method) (Katoh et al., 2002, 2005).
2.5. qRT-PCR study of transcript levels
The cDNA synthesised in x 2.2 was used as template to deter-
mine the relative transcript levels of the TricaDop3 receptor. They
were quantified using the Fast Sybr Green assay kit (Applied Bio-
systems) in a StepOne Plus detection system (ABI Prism, Applied
Biosystems). Primers (sense primer 50-TCGGCAACGTGCTTGTGAT-30
and antisense primer 50-TTAGTGGCCGACTGCAGAGTT-30) (Sigma-
eAldrich) were used in final concentrations of 500 nM. Reactions
were run in duplicate and incubated at 50 C for 2 min, followed by
95 C for 10 min, followed by 40 cycles of [95 C for 15 s and 60 C
for 1 min]. The specificity of the PCR products was assessed by
generating a dissociation curve (95 C for 15 s, 60 C for 1 min, and
increases in temperature in 0.7 C increments from 60 C to 95 C).
Analysis of the dissociation curves of the different amplification
products revealed a single melting peak. We detected no amplifi-
cation of the fluorescent signal in the negative control samples (no
template control, RT ¼ RNA sample as template), proving that the
extraction procedure, including the DNase treatment, effectively
removed genomic DNA from all the RNA samples and that there
was no contamination. Agarose gel electrophoresis of the PCR
products confirmed the presence of a single band of the expected
size and sequencing confirmed their identity. The relative quantity
of target cDNA was quantified using the DDCT-method including
normalisation to the geometric mean (a type of mean or average,
which indicates the central tendency or typical value of a set of
numbers by using the product of their values as opposed to their
sum) of a selection of endogenous control genes. From a list of eight
housekeeping genes (Supplementary table), both ribosomal pro-
teins RPs3 and RPs18, and actin were selected using geNorm
(Vandesompele et al., 2002) as stable genes with respect to sex and
tissue and used as endogenous controls (Vuerinckx et al., 2011).
2.6. Cell culture and transfections
Preliminary pharmacological analyses were performed in Chi-
nese hamster ovary (CHO) WTA11 cells stably co-expressing the
bioluminescent protein apoaequorin (Brough and Shah, 2009) and
the promiscuous Ga16 subunit, which couples most agonist-
induced GPCRs to the phospholipase C and Ca2þ pathway, irre-
spective of their natural signalling cascade (Milligan et al., 1996;
Offermans and Simon, 1995; cells were obtained from the Free
University of Brussels and Euroscreen, Belgium). In subsequent
experiments, CHO-PAM28 cells stably expressing apoaequorin, but
not the promiscuous Ga16 (Free University of Brussels and Euro-
screen, Belgium), and human embryonic kidney (HEK) 293 cells
(Invitrogen) were used to measure TricaDop3's downstream sig-
nalling properties via Ca2þ and cAMP, respectively (Dillen et al.,
2013).
CHO-WTA11 cells, CHO-PAM28 cells and HEK 293 cells were
cultured in monolayers in Dulbecco's Modified Eagles Medium
nutrient mixture F12-Ham (DMEM/F12) (SigmaeAldrich) supple-
mented with 100 IU/ml penicillin and 100 mg/ml streptomycin
(Gibco) to prevent bacterial contamination of gram-positive and
gram-negative bacteria, respectively. For CHO cells the medium
was also supplemented with 10% heat-inactivated fetal bovine
serum (Gibco). The medium used for HEK 293 cells was supple-
mented with Ultroser G (Crescent Chemical Company). For CHO-
WTA11 cells, 250 mg/ml zeocin (Gibco) was added to the me-
dium, whereas for CHO-PAM28 cells, 5 mg/ml puromycin (Sigma-
eAldrich) was added to the medium. Puromycin and zeocin were
initially used to select for cells stably expressing apoaequorin (CHO-PAM28) (Torfs et al., 2002), or both apoaequorin and Ga16 (CHO-
WTA11 cells) (Blanpain et al., 1999) and are thus still used as
additional antibiotics in the appropriate screens. All cells were
maintained in an incubator at 37 C with a constant supply of 5%
CO2.
Transfections with pcDNA3.1-TricaDop3 or empty pcDNA3.1
vector were carried out in T75 flasks at 60e80 % confluency.
Transfection medium for CHO cells was prepared using the Lip-
ofectamine LTX Kit (Invitrogen) with 2.5 ml Opti-MEM® (Gibco),
12.5 ml Plus™ Reagent and 5 mg vector construct (pcDNA3.1-Trica-
Dop3 or empty pcDNA3.1 vector) in 5ml polystyrene round-bottom
tubes. After a 5 min incubation period at room temperature, 30 ml
LTX was added to the medium. After a further incubation period of
30 min at room temperature, the medium was removed and DNA/
LTX mix was added dropwise to the cells followed by 3 ml of fresh
complete medium. The transfection medium used for HEK293 cells
was similar to that used for CHO cells except that in addition to 4 mg
of pcDNA3.1-TricaDop3 expression construct (or empty pcDNA3.1
vector plasmid) cells were co-transfected with 2 mg of reporter
CRE(6x)-Luc plasmid. This reporter plasmid contains six tandem
repeats of a cAMP Responsive Element (CRE) in front of a minimum
collate promoter and the ORF of luciferase (this reporter plasmid
was also used in various other studies: for example Hearn et al.,
2002; Johnson et al., 2004). To test whether the concentration of
receptor used for the transfection affects the cAMP concentration
the same transfection was also carried out with 1 and 8 mg of
pcDNA3.1 receptor expression construct.
Following transfection, cells were incubated overnight (37 C,
5% CO2), then 10ml of cell mediumwas added followed by a second
overnight incubation (37 C, 5% CO2). Ligand-induced changes in
either, intracellular Ca2þ or cAMP were then monitored in the cells
as described below.
2.7. Calcium reporter assay in CHO cells
CHO cells transfected with vector construct (pcDNA3.1-Trica-
Dop3 or empty pcDNA3.1 vector) were detached with PBS,
complemented with 0.2% EDTA (pH 8.0), and rinsed off the flask
with complete DMEM/F12. The number of viable and nonviable
cells was determined using a NucleoCounter® NC-100™ (Che-
mometic). The cells were pelleted for 5 min at 800 rpm and
resuspended to a density of 5  106 cells/ml in sterile filtered
bovine serum albumin (BSA) medium (DMEM/F12 with L-gluta-
mine and 15 mM Hepes, without phenolred, supplemented with
0.1% BSA) and loaded with 5 mM Coelenterazine_h (Invitrogen) for
4 h in the dark, at room temperature, while gently shaking to
reconstitute the holo-enzyme aequorin. After a tenfold dilution,
cell solution (50 ml) was delivered to each well in a 96-well plate
(~25000 cells/well) and cells were exposed to potential ligands
reconstituted in BSA medium and distributed across the plate. In
every row, BSA medium without potential ligands was placed in
one well to serve as the blank for that row. The calcium response
was recorded for 30 s on a multimode microplate reader Mithras
LB 940 at a wavelength of 469 nm (Berthold Technologies). After
30 s, 0.1% Triton X-100, a non-ionic surfactant, was added to the
same well to measure the total cellular Ca2þ response. The total
response (ligand þ Triton X-100), which is directly related to the
number of cells present in the well, was used to normalise the
response for possible different amounts of cells per well. The
response of each blank (small signal caused by cells ruptured by
the injection in the wells) was subtracted from the luminescence
obtained for wells within the same row. Calculations were made
using the output file from the Microwin software (Berthold
Technologies) in Excel (Microsoft). Further analysis was done in
Excel and GraphPad Prism 5.
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To monitor changes in intracellular cAMP levels, HEK293 cells
co-transfected with receptor construct (pcDNA3.1-TricaDop3 or
empty pcDNA3.1 vector) and reporter CRE(6x)-Luc plasmid were
detached with PBS, complemented with 0.2% EDTA (pH 8.0), and
rinsed off the flask with complete DMEM/F12. The number of viable
and nonviable cells was determined using the NucleoCounter® NC-
100™. The cells were pelleted for 5 min at 800 rpm and finally
resuspended to a density of 1 106 cells/ml in DMEM/F12 without
phenolred (Invitrogen), but containing 200 mM 3-isobutyl-1-
methylxanthine (IBMX, SigmaeAldrich) to prevent cAMP break-
down. Into each well of a white 96-well plate 50 ml of cell sus-
pension (~50000 cells/well) was added to either 50 ml of phenol
red-free DMEM/F-12 with IBMX (to prevent breakdown of cAMP)
or phenol red-free DMEM/F-12 with IBMX containing 10 mM NKH-
477 (a forskolin analogue), which was used to enhance cAMP levels
in the cells. In each row of the plate at least one well with only
phenol red-free DMEM/F-12 with IBMX was measured. This well is
used to calculate the ‘blank’ level (Fig. 8). The cells were then
incubated (37 C, 5% CO2) for 3e4 h. Thereafter, 100 ml of steadylite
plus™ substrate (PerkinElmer) was added to each well using a
multichannel pipette and the plate was incubated for 15 min in the
dark. Finally, light emission resulting from the luciferase enzymatic
activity was recorded for 0.2 s/well every 55 s during 10 cycles on a
multimode microplate reader FLUOstar Omega at a wavelength of
469 nm (BMG Labtech). Results were analysed by means of the
Omega software and further processed by Excel and GraphPad
Prism5 software.
2.9. Drugs
The pharmacological ligands (±)-2-amino-6,7 e dihydroxy e
1,2,3,4 e tetrahydronaphthalene hydrobromide (6,7-ADTN), 3-
hydroxytyramine (dopamine, DA), bromocriptine mesilate, 5-
methoxytryptamine (5-MT), (þ)-butaclamol hydrochloride, chlor-
promazine hydrochloride, cis-(Z)-flupenthixol, DL-octopamine hy-
drochloride, ketanserin (þ)-tartrate, methiothepin mesylate,
methysergide maleate, mianserin hydrochloride, prazosin hydro-
chloride, SB-269970 hydrochloride, tyramine hydrochloride, WAY-
100635 maleate (WAY ¼ N-(2-[4-(2-methoxyphenyl)-1-
piperazinyl]-ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide), spi-
perone (N-(p-Isothiocyanatophenethyl)spiperone hydrochloride),
NKH-477 and yohimbine hydrochloride were purchased from
SigmaeAldrich.
3. Results
3.1. Cloning and sequence analysis of TricaDop3
The PCR amplified a single cDNA fragment encoding a Dop3
from T. castaneum. The open reading frame of Tricadop3 contains
1641 nucleotides encoding the TricaDop3 protein of 546 amino
acids (Fig. 1) with a calculated molecular weight of 60.16 kDa.
Transmembrane topology prediction revealed the presence of
seven putative transmembrane domains (TM1-7), characteristic of
all GPCRs. The large third intracellular loop and the short intra-
cellular C-terminal region are typical features of biogenic amine
receptors that couple via Gi (Gerhardt et al., 1996; Kroeze et al.,
2002) and are also found in mammalian D2-like DA receptors
(Missale et al., 1998). At the N-terminus of the second intracellular
loop is the highly conserved DRY sequence (D3.49R3.50Y3.51)
[numbering according to the Ballesteros-Weinstein system
(Ballesteros and Weinstein, 1995), believed to have a key role in
receptor activation (Bockaert and Pin, 1999; Gether, 2000)]. Morespecific sequence characteristics for biogenic amine receptors are
present as well. Two aspartate residues in TM2 and TM3 (D2.50 and
D3.32) that are conserved in all catecholamine receptors are thought
to play a role in binding the protonated amine moiety of cate-
cholamines (Chung et al., 1988; Fraser et al., 1988; Ho et al., 1992;
Strader et al., 1987, 1988). The combination of this D3.32 in TM3
with the conserved W7.40 in TM7 is considered a unique fingerprint
for biogenic amine and trace amine GPCRs (Huang, 2003; Spitzer
et al., 2007). As in other biogenic amine receptors, TricaDop3 has
a hydrophobic ligand binding pocket consisting of mainly aromatic
amino acids residues from TM4-TM7 (W4.50 in TM4, F5.47 in TM5,
W6.48, F6.51, F6.52 in TM6, and W7.40, Y7.43 in TM7) (Roth et al., 1997).
Moreover, as for all catecholamine receptors, three conserved
serine residues in TM5 are postulated to be hydrogen bond donors
to bind the catecholamine ring hydroxyl groups (S5.42, S5.43, and
S5.46) (Pollock et al., 1992; Strader et al., 1989). The alignment shows
a fourth conserved serine residue in the insect Dop3 receptors,
possibly involved in hydrogen bonding to DA. In addition, a disul-
phide bond between C3.25 and C5.31 in extracellular loop 1 and 2
respectively, is believed to stabilise the functional receptor struc-
ture (Dixon et al., 1987; Fraser, 1989; Karnik and Khorana, 1990;
Karnik et al., 1988; Noda et al., 1994).
In TM6, the consensus sequence of non-peptide receptors
(F6.44xxxW6.48P6.50) is followed by a pair of Phe residues (F6.51 and
F6.52) unique to aminergic receptors. In TM7, the N7.49P7.50xxY7.53
motif is conserved. Mutagenesis experiments along this domain
have been shown to affect the receptor's ligand affinity, G protein
coupling, receptor signalling, desensitisation and internalisation
(Barak et al., 1994; Birse et al., 2006; Borroto-Escuela et al., 2011;
Fritze et al., 2003; Gales et al., 2000; Gripentrog et al., 2000;
Kalatskaya et al., 2004).
As for most GPCRs, consensus motifs for N-linked glycosylation
(N-x-[S/T]) (Marshall, 1974; Swarz and Aebi, 2011) are found in the
extracellular N-terminus, and consensus sites for phosphorylation
by protein kinase C (PKC) ([S/T-X-[R/K]) (Woodgett et al., 1986) are
located within the third intracellular loop (Fig. 1).
Comparison of the Dop3 amino acid sequences of A. mellifera,
D. melanogaster and T. castaneum revealed high sequence similar-
ities. Overall sequence similarity of TricaDop3 (identical and
conservatively substituted amino acids) compared to insect Dop3
orthologues is 78.0% for A. mellifera (GenBank Accession Number
AAX62923) and 71.3% for D. melanogaster (GenBank Accession
Number Q8IS44.1). Sequence similarity is even higher within the
TM regions: 96.9% for A. mellifera and 96.3% for D. melanogaster.
3.2. Transcript level study
An initial tissue distribution screen of TricaDop3 mRNA in
sexually mature beetles was performed using qRT-PCR (Fig. 2).
Transcript levels of the Tricadop3 gene were relatively high in the
head compared to the gut, fat body, gonads and accessory gland. No
significant differences could be detected between males and fe-
males (Fig. 2A). In an additional experiment in sexually mature
males it appears that the transcript levels of the Tricadop3 gene are
especially pronounced in the central nervous system, represented
by the central brain and optic lobes (Fig. 2B).
3.3. Pharmacological characterisation of TricaDop3
In order to begin our pharmacological characterisation of Tri-
caDop3 receptors, we used CHO-WTA11 cells stably expressing
aequorin and the promiscuous Ga16 subunit. No alteration of the
signal was observed when cells transfected with empty pcDNA3.1
vector were incubated with DA (results not shown). A significant
response, however, was obtained upon application of micromolar
Fig. 1. Amino acid sequence alignment of the Tribolium castaneum Dop3 sequence (TricaDop3, GenBank Accession Number EFA02832) and sequences of orthologous receptors
from Apis mellifera (ApimeDop3, GenBank Accession Number AAX62923) and Drosophila melanogaster (DromeDop3, GenBank Accession Number Q8IS44.1). The amino acid position
is indicated on the right. Identical residues between all the sequences are highlighted in black and conservatively substituted residues in grey. Dashes indicate gaps that were
introduced to maximise homologies. Putative transmembrane regions (TM1-TM7) are indicated by grey bars. Open diamonds (◊) indicate putative N-linked glycolysation sites and
dots (C) indicate putative phosphorylation sites for PKC.
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micromolar concentrations of potential synthetic agonists were
subsequently tested (Fig. 3, Table 1). The biogenic amines octop-
amine and tyramine induced a clear signal at concentrations of
100 mM (but not of 1 mM). The mammalian D2-selective receptor
agonist bromocriptine and the mixed D1/D2-like receptor agonist
6,7-ADTN induced signals that were similar in magnitude to those
measured for DA. An agonist of 5-HT-receptors, 5-MT, also induced
considerable receptor activation. The doseeresponse relationships
for DA, tyramine and the two potent synthetic dopaminergic ago-
nists were examined at concentrations ranging from 0.01 nM to
10mM (Fig. 4). The resulting sigmoidal doseeresponse curves show
receptor activation in a dose-dependent and saturable manner. For
the natural agonist DA, half-maximal activation (EC50) was ach-
ieved at DA concentrations of 640 nM [510e810 nM, 95% confi-
dence interval (CI)]. The maximal response was attained at DA
concentrations of 100 mM. Since the efficacy achieved by any
agonist depends on the number of receptors expressed, we
measured a doseeresponse curve for DA in every experiment and
normalised all agonist effects to the maximum DA response, set at
100% (Fig. 4). The EC50 values of the synthetic agonistsbromocriptine and 6,7-ADTN were 1.2 mM (0.8e1.7 mM, 95% CI) and
2.8 mM (2.0e3.8 mM, 95% CI), respectively. Tyramine had an EC50
value of 60 mM (51e71 mM, 95% CI), and concentrations in the
micromolar range are needed to induce any response (Figs. 3 and
4). The rank order of potencies thus is DA  bromocriptine 6,7-
ADTN > tyramine, with only subtle differences between the first
three potent agonists (Figs. 3 and 4, Table 1).
Potential antagonists were tested by simultaneously applying
DA (1 mM) and a high dose of antagonist (100 mM) to TricaDop3-
expressing CHO-WTA11 cells. In TricaDop3-expressing CHO-
WTA11 cells, the mammalian DA receptor antagonist spiperone
and the mammalian 5-HT receptor antagonists ketanserin,
methiothepin, prazosin, SB-269970 and WAY-100635 had no effect
on DA signalling at the used concentrations. However, butaclamol
and chlorpromazine (two mammalian DA receptor antagonists)
and yohimbine (an antagonist of vertebrate a2 receptors) inhibited
the DA response by about 40%, while the DA receptor antagonist
flupenthixol blocked about 60% of the DA response (Table 1).
Interestingly, mianserin and methysergide, generally known as
antagonists of mammalian 5-HT receptors, were the most potent
blockers of DA signalling with an inhibition of respectively 80% and
Fig. 2. Expression profiles of transcripts encoding TricaDop3 in sexually mature beetles (12d adult). The data represent mean values of (A) three independent samples of
30  heads, 50  guts, 20  fat body and 50  reproductive system; and (B) three independent samples of 15 beetles each; run in duplicate þ SEM, normalised relative to the
geometric mean of RPs3 (ribosomal protein 3), RPs18 and b-actin transcript levels. Abbreviations: FB, fat body; Acc Gl, accessory glands; Brain, brain without the optic lobes; OL,
optic lobes; SalGl, salivary glands.
Table 1
Indication of activation by agonists (100 mM) or inhibition by antagonists (100 mM; in
H. Verlinden et al. / Insect Biochemistry and Molecular Biology 56 (2015) 9e2014100% (in presence of 100 mMantagonist and 1 mMDA). The effects of
methysergide and mianserin were tested into more detail in Tri-
caDop3-expressing CHO-WTA11 cells using two different concen-
trations of DA. Significant inhibition of the DA response was
measured using micromolar concentrations of the antagonists,
with methysergide being clearly the most potent blocking agent
(Fig. 5). The nature of this inhibition was further examined by
studying the doseeresponse relationship of DA in the presence of
methysergide at several different concentrations (Fig. 6). The
higher the concentration of antagonist, the higher was the resulting
EC50 value for DA activity. The corresponding pA2 value (i.e. the
logarithm of the concentration of antagonist that doubles the
amount of DA required for obtaining the same effect) was calcu-
lated using the Gaddum/Schild plot (Kenakin, 1982). The pA2 value
(±SEM) was 5.74 (±0.15). Since the efficacy did not change, it is very
likely that methysergide behaved as a truly competitive antagonist
on TricaDop3 in presence of DA. A high dose (100 mM) of all active
chemicals was also tested on cells transfected with empty
pcDNA3.1 vector and could not induce a signal in these cells.presence of 1 mMDA) of the TricaDop3 receptor activity in CHO-WTA11 and HEK293
cells. Abbreviations used: DA, dopamine; 6,7-ADTN, (±)-2-amino-6,7 e dihydroxy e
1,2,3,4 e tetrahydronaphthalene hydrobromide; 5-MT, 5-methoxytryptamine (5-
MT), WAY, N-(2-[4-(2-methoxyphenyl)-1-piperazinyl]-ethyl)-N-(2-pyridinyl)
cyclohexanecarboxamide. The agonists 5-MT and octopamine showed ~72 and 49%
of the DA response (indicated asþþ andþ) at 100 mM concentration. Antagonists (at3.4. Downstream signalling properties of TricaDop3
CHO-PAM28 and HEK293 cells were used to determine the
downstream signalling pathway of TricaDop3. Again, no alterationFig. 3. Activation of TricaDop3 in CHO-WTA11 cells by agonists at two different
concentrations. Bioluminescence levels measured in blanks were subtracted and the
data are presented relative to responses obtained using 100 mM dopamine alone
(100%). The bars represent mean values þ SEM. Abbreviations used: DA, dopamine; OA,
octopamine; TA, tyramine; ADTN, 6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol
hydrobromide; Bromo, bromocriptine; 5-MT, 5-methoxytryptamine. Measurements
were performed in triplicate.of the signal was observed when either of these cell lines, trans-
fected with empty pcDNA3.1 vector, was incubated with DA (results
not shown). Calcium signals in response to DA concentrations
ranging from 0.01 nM to 1 mM were monitored in TricaDop3-
expressing CHO-PAM28 cells. Responses to DA application were
dose dependent, indicating that even without the presence of the
promiscuous Ga16, the activation of the TricaDop3 receptor affects
intracellular calcium levels (Fig. 7). An EC50 value of 0.6 mM
(0.24 mM e 1.5 mM, 95% CI) was measured. Effects of DA on intra-
cellular cAMP levels were examined in TricaDop3-expressing
HEK293 cells using DA concentrations ranging from 0.01 nM to
10 mM. DA caused a dose-dependent decrease in NKH-477-
stimulated cAMP levels in these cells (Fig. 8). Half maximal
reduction of cAMP was observed at 6 mM (3.5e10 mM, 95% CI) DA.
TricaDop3 thus inhibits cAMP production, probably via the Gaiconcentration of 100 mM) that showed ~40% inhibition of a 1 mM DA response are
indicated þ, the ones that showed ~60 % inhibition are indicated þþ, antagonists
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5-MT þþ þ















Fig. 4. Dose-response (Ca2þ) curves of agonists applied to TricaDop3-expressing
CHO-WTA11 cells also stably expressing Ga16. Bioluminescence levels measured in
blanks were subtracted and the 100% level is representative for responses obtained
using 100 mM dopamine alone. Responses to dopamine (DA) were measured six times
in duplicate; responses to 6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol hydro-
bromide (ADTN) and bromocriptine (Bromo) were measured four times in duplicate
and responses to tyramine (TA) were measured twice in duplicate.
Fig. 6. Effects of methysergide on dopamine (DA) doseeresponse curves measured
in TricaDop3-expressing CHO-WTA11 cells. Bioluminescence levels measured in
blanks were subtracted and the data are presented relative to responses obtained using
100 mM dopamine alone (100%). Measurements were performed three times in
duplicate. The pA2 value of methysergide is 5.74.
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responses to NKH-477, increasing cAMP to a level higher than that
recorded in response to NKH-477 alone, with mean responses to
NKH-477 alone around 70% of maximum (Fig. 8). It is also inter-
esting to note that when DA was applied at concentrations greater
than 30 mM, cAMP levels fell below the level detected in the ‘blank’
measurement: cells expressing TricaDop3 that had not been
exposed to either NKH-477 or DA and which are added to medium
with IBMX (see x 2.8) (‘blank’, Fig. 8). In blanks, cAMP levels were
approximately 20% higher than in cells exposed to NKH-477
together with high doses of DA (Fig. 8).
The antagonists that were tested initially on DA responses eli-
cited from CHO-WTA11 cells stably expressing apoaequorin and the
promiscuous Ga16 subunit were tested again to determine their
effect on DA-induced decreases in intracellular cAMP levels in Tri-
caDop3-expressing HEK293 cells. As before, the effects of antago-
nists at a concentration of 100 mMwere tested against responses to
1 mM DA. At this concentration, butaclamol, chlorpromazine, flu-
penthixol and spiperone failed to block DA-induced decreases in
intracellular cAMP levels. Ketanserin, methiothepin, prazosin, SB-Fig. 5. Activation of TricaDop3 in CHO-WTA11 cells by dopamine (100 mM, 1 mM) in
the presence of 100 mM antagonist. Bioluminescence levels measured in blanks were
subtracted and the data are presented relative to responses obtained in the presence of
either, 1 mM or 100 mM dopamine (100%), as appropriate. The bars represent mean
values þ SEM. Measurements were performed twice in triplicate. Abbreviation used:
DA, dopamine.269970, WAY-100635 and yohimbine were also found to be inef-
fective at this concentration. However, methysergide and mian-
serin, the most potent inhibitors of the response in CHO-WTA11
cells, also reduced DA-induced changes in cAMP levels in Trica-
Dop3-expressing HEK293 cells (Table 1, Fig. 9). A high dose
(100 mM) of all active chemicals was also tested on cells transfected
with empty pcDNA3.1 vector and could not induce a signal in these
cells (results not shown).
To test whether the presence of TricaDop3 in itself affects
intracellular cAMP levels, three different concentrations (1 mg, 4 mg
and 8 mg) of pcDNA3.1-TricaDop3 vector were used for transfection
of HEK293 cells. For each group of cells, a range of DA concentra-
tions was tested and compared to the response of cells transfected
with empty pcDNA3.1 vector. The results of this experiment indeed
suggest that the presence of the receptor alters cAMP levels even in
the absence of DA. Fig. 10 shows that both in the presence and
absence of NKH-477, the higher the concentration of receptor
construct used for transfection, the lower the level of cAMP that
was detected, prior to the application of DA.We also testedwhether
the transfection concentration affects the response of the cells to
DA. For purposes of comparison, cAMP levels are presented relative
to the levels detected in cells transfected with 1 mg of TricaDop3,Fig. 7. Dopamine (DA)-induced changes in calcium levels in TricaDop3-expressing
CHO-PAM28 cells. Bioluminescence levels measured in blanks were subtracted and
the data are presented relative to responses obtained using 100 mM dopamine alone
(100%). All measurements were performed four times in duplicate.
Fig. 8. Dopamine (DA)-induced changes in intracellular cAMP in TricaDop3-
expressing HEK293 cells measured in the presence of 10 mM NKH-477. The 100%
level represents the activation of the receptor by 1 nM of dopamine in the presence of
10 mM of NKH-477 (a forskolin analogue) and 0% represents the level of activation of
the receptor by 10 mM of dopamine in the presence of 10 mM of NKH-477. The mea-
surements were performed six times in duplicate. Horizontal lines are used to indicate
the levels of cAMP detected in the presence of 10 mM NKH-477 but without DA (‘NKH-
477’), and in the absence of both NKH-477 and DA (‘blank’).
Fig. 10. Effect on cAMP levels of using different expression vector (with the Tri-
caDop3) concentrations for transfection of HEK293 cells in absence of dopamine
(DA). The bars represent the bioluminescence measured in cells transfected with
empty vector or different concentrations of the TricaDop3 expression vector in the
presence or absence of 10 mM NKH-477. Higher concentrations of receptor construct
used for transfection led to lower cAMP levels. The measurements were performed in
triplicate.
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values obtained using the three different transfection concentra-
tions do not differ significantly and in all cells, responses to DA at
the highest concentration tested are equally low (Fig. 11).
4. Discussion
4.1. Sequence information
In this study we describe the cloning of cDNA encoding a
dopamine Dop3 receptor from T. castaneum. The hydrophobicity
profile revealed seven putative membrane-spanning segments, a
structural feature shared by all members of the GPCR superfamily.
These receptors are commonly glycosylated, a posttranslational
modification involved in receptor stability, turnover and targetingFig. 9. Effects of 3 different concentrations of the antagonists, mianserin and
methysergide on responses to DA (100 mM) in TricaDop3-expressing HEK293 cells
treated with 10 mM NKH-477. The bars represent the bioluminescence as a result of
changes in NKH-477 (10 mM) induced intracellular cAMP levels in presence of 100 mM
dopamine and different concentrations (10 nM, 1 mM or 100 mM) of antagonist
(mianserin or methysergide) þ SEM. The 100% level represents the bioluminescence
measured in the presence of 1 nM of dopamine and 10 mMNKH-477, and 0% represents
the bioluminescence in the presence of 100 mM DA and 10 mM NKH-477. 100 mM of
mianserin and concentrations higher than 1 mM of methysergide significantly reduce
the function of DA. The measurements were performed in duplicate.to themembrane (Clagett-Dame andMcKelvy,1989). TricaDop3 has
eight Asn residues at its N-terminal end for potential glycosylation.
Posttranslational phosphorylation of residues in the third intra-
cellular loop and C-terminus of the receptors is believed to be
involved in receptor desensitisation (Butcher et al., 2012). Trica-
Dop3 contains one Thr and four Ser residues for phosphorylation by
PKC. Several sequence characteristics necessary for dopamine
binding are present. Of particular note is a series of Ser residues in
TM5 that are supposed to interact with the catecholamine ring of
DA (Pollock et al., 1992; Strader et al., 1989).
Amino acid sequence similarity was highest with insect Dop3
receptors. Indeed, similarities with Dop3 orthologues from
D. melanogaster and A. mellifera are high, reaching more than 96%
within the transmembrane regions (Fig. 1). Such high percentages
are comparable with similarities between other biogenic amine
receptor orthologues in insects (Vleugels et al., 2013, 2014).
4.2. Transcript level study
Tricadop3 transcript levels are high in the central nervous tissue
of the head, namely the central brain and the optic lobes. This is in
accordance with the general perception of a neurotransmitter role
for DA and is consistent with previous studies in insects. In the fruitFig. 11. Effect on NKH-477 stimulated cAMP levels of different expression vector
concentrations for transfection of HEK293 cells in presence of different amounts
of dopamine (DA). The 100% level represents the cAMP level of cells transfected with
1 mg of receptor construct and exposed to 10 mM of NKH-477. The 0% level represents
the level of activation of the receptor by 10 mM of dopamine in the presence of 10 mM
of NKH-477. The measurements were performed in triplicate.
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important role in early neural development and central nervous
system function has been suggested (Wiemerslage et al., 2013);
FlyAtlas, URL: http://www.flyatlas.org). Functional data in
T. castaneum were obtained using RNA interference (RNAi), which
induced high mortality during the larval stage and impaired moult
to the pupal stage (Bai et al., 2011). TricaDop3 is therefore suggested
to play an important role during larval growth and development,
perhaps by modulating neural development and locomotor activity
as reported in D. melanogaster (Draper et al., 2007; Wiemerslage
et al., 2013). Expression in the brain is also in line with Dop3
expression in the honey bee. In situ hybridisation analysis of Api-
meDop3 in the brain of adult honey bees showed expression in the
Kenyon cells of the mushroom body. Expression of this receptor
was also observed in cells around the antennal lobes and cells
associated with the optic lobes. As a result, ApimeDop3 is suggested
to play a role in the processing of information of sensory pathways
in the brain (Beggs et al., 2005).
4.3. Receptor pharmacology
Pharmacological analysis identified bromocriptine and 6,7-
ADTN as effective agonists of TricaDop3 in CHO-WTA11 cells, both
with a potency and efficacy comparable to DA. Also in ApimeDop3
expressing HEK293 cells, bromocriptine induced a decrease in
cAMP equally large as DA (10 mM) (Beggs et al., 2005). On Drome-
Dop3, bromocriptine was more potent than DA at decreasing
intracellular cAMP levels (with EC50 values varying from 1.4 to
2.1 nM for bromocriptine, and 0.3e0.4 mM for DA) (Hearn et al.,
2002). Both DA and bromocriptine at maximally effective concen-
trations induced a more than tenfold decrease in luciferase activity
(vs. basal). Bromocriptine thus seems to be a potent and effective
agonist for insect Dop3 receptors. Bromocriptine is reported to have
minor agonist activity on DromeDop2 (Reale et al., 1997a), and no
agonist activity was measured on Dop2 from Periplaneta americana
(Troppmann et al., 2014). It may thus be a good candidate to
pharmacologically distinguish D2-like receptors from D1-like re-
ceptors and INDRs in insects. The agonist 6,7-ADTN has been shown
to have some activity on DromeDop3, but also on other DA receptor
subtypes in D. melanogaster, A. mellifera and P. americana (Mustard
et al., 2003; Sugamori et al., 1995; Troppmann et al., 2014). An
agonist of 5-HT-receptors, 5-MT, (Thamm et al., 2010; Troppmann
et al., 2010; Vleugels et al., 2013, 2014) also induced considerable
receptor activation.
Because of the suggested phylogenetic relationship between
insect Dop3 receptors and tyramine receptors (Beggs et al., 2011),
we also tested tyramine on our receptor. However, tyramine was
much less potent in activating TricaDop3 than DA (Figs. 3 and 4).
Also in A. mellifera high concentrations (>10 mM) of tyramine were
needed to decrease intracellular cAMP levels (Beggs et al., 2005).
However, tyramine has been found to have a relatively high po-
tency on DromeDop3 (EC50 around 10 mM), as well as some other
biogenic amines such as serotonin and (nor)epinephrine (Hearn
et al., 2002).
For insect Dop3 receptors, almost no pharmacological data are
available concerning potent antagonists. A high concentration of
flupenthixol, an antagonist known to inhibit mammalian dopamine
(D1-D5), serotonin (5-HT2), adrenaline (a1), and histamine (H1)
receptors, as well as insect Dop1 and Dop2 receptors (Blenau et al.,
1998; Han et al., 1996; Hearn et al., 2002; Mustard et al., 2003,
2005; Reale et al., 1997a; Srivastava et al., 2005), was able to
inhibit the DA-induced reduction of cAMP levels in DromeDop3-
expressing cells (Hearn et al., 2002), but was not active on Apime-
Dop3 (Beggs et al., 2011) or on TricaDop3 when expressed in
HEK293 cells. However, whenwe expressed the TricaDop3 receptorin CHO-WTA11 cells stably expressing aequorin and the promis-
cuous Ga16 subunit, 100 mM flupenthixol was able to inhibit the DA
signalling. This was also the case for butaclamol, chlorpromazine
and yohimbine. Either the type of assay influences the outcome or
possibly these antagonists only block the Ca2þ signalling and not
the cAMP signalling.
We identified methysergide, known as a non-selective antago-
nist of mammalian 5-HT receptors, as a potent antagonist for Tri-
caDop3. It showed characteristics of competitive inhibition in the
presence of DA in CHO-WTA11 cells. R€oser et al. (2012) have shown
that, in the blowfly, methysergide activates 5-HT7 but inhibits 5-
HT2a-mediated responses. In the honey bee, methysergide dis-
plays high potency at 5-HT2a but does not block 5-HT2b (Thamm
et al., 2013). It was also shown to be a relatively potent competi-
tive inhibitor of 5-HT1-type and 5-HT7-type serotonin receptors of
T. castaneum (Vleugels et al., 2013, 2014).
4.4. Signalling properties
When looking at the downstream coupling of the receptor, Tri-
caDop3was able to activate a calcium signalling pathway, as well as
to decrease the intracellular levels of cAMP. The concentrations
needed to achieve the half-maximal calcium signal in the two CHO
cell lines used, were around 0.6 mM. These EC50 values are similar in
magnitude to those reported for cAMP signalling of DA receptors
from D. melanogaster and A. mellifera (Han et al., 1996; Hearn et al.,
2002;Mustard et al., 2005; Sugamori et al., 1995). However, the IC50
value in TricaDop3-expressing HEK293 cells was about 10 times
higher (6 mM). This might indicate that this receptor is more potent
in signalling via calcium, than in inhibiting the cAMP pathway.
However, the use of different cell types might also be responsible,
at least in part, for these differences in EC50/IC50 values, or even for
differential second messenger coupling. Indeed, different cell lines
may differ in the number of receptors expressed at the plasma
membrane, in the levels of interacting proteins (including different
G proteins), in the effector systems generating second messengers
and/or in cellular metabolism. Also, possible differences between
effects observed in cultured cell lines and intracellular processes
occurring within the in vivo context of an organism should be taken
into account.
In vertebrates, D2-like receptors are coupled to Gi/o proteins and
negatively regulate AC activity, resulting in a decrease of cAMP
production and subsequently decreased PKA activity (Enjalbert and
Bockaert, 1983; Kebabian and Calne, 1979; Kebabian and
Greengard, 1971; Missale et al., 1998). The Dop3 receptors from
D. melanogaster and A. mellifera were also shown to induce a
decrease in intracellular cAMP levels in vitro (Beggs et al., 2005;
Beggs and Mercer, 2009; Hearn et al., 2002). Our study also
showed that Dop3 receptor activation can also influence intracel-
lular calcium levels. This response might be attributed to Gaq pro-
teins, but as well to Gbg signalling. Indeed, Clark and Baro (2007)
surprisingly showed an increase in intracellular cAMP levels upon
application of DA to HEK293 cells expressing Dop3 from A. mellifera
or the lobster Panulirus interruptus. They showed that the
P. interruptus Dop3 receptor stimulates Gi/o protein activity, leading
to the activation of two pathways: a Ga-mediated inhibition of AC
and a Gbg-mediated activation of phospholipase C leading to an
increase in cAMP. Also mammalian D2-like receptors are able to
regulate AC activity via Gbg-mediated activation of phospholipase C
(Tsu and Wong, 1996). In addition, mammalian D2-like receptors
can modulate intracellular calcium levels by acting on ion channels
or by triggering the release of intracellular calcium stores, partly
due to Gbg activity (Beaulieu & Gainetdinov, 2011; Hernandez-
Lopez et al., 2000; Missale et al., 1998; Nishi et al., 1997; Yan
et al., 1997).
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features. First, trace amounts of DA appear to enhance responses of
this receptor to NKH-477, elevating cAMP in the cells to levels
above those detected in response to NKH-477 alone (Fig. 8). Basal
levels of cAMP, on the other hand, were affected by the concen-
tration of pcDNA3.1-TricaDop3 transfected into the cells; the higher
the concentration of receptor construct the lower the basal cAMP
levels recorded in the cells (Figs. 10 and 11). Previous studies on
Dop3 receptors report similar features (Beggs et al., 2005; Clark and
Baro, 2007). One possible explanation could be that trace amounts
of DA cause a conformational change in the receptor protein that
affects receptor function, leading to increases in cAMP levels in
response to receptor activation. In the presence of higher DA con-
centrations, the receptor may assume a different conformation and
as a result, receptor activation leads to a decline in levels of cAMP.
Interestingly, receptors with dual coupling properties can
display agonist-dependent functional differences, as was first
shown for biogenic amine GPCRs of Drosophila (Reale et al., 1997a;
Robb et al., 1994). Indeed, different agonists/antagonists may
induce different conformational changes of a receptor. Different
receptor conformations in their turn can facilitate coupling to a
specific effector protein thereby favouring a particular downstream
signalling pathway. In insect neuropeptide receptors, such agonist-
dependent, receptor-mediated differences in downstream coupling
behaviour have been suggested to contribute to the physiological
fine-tuning by naturally occurring variants of a given peptide family
(Dillen et al., 2013; Poels et al., 2004, 2005).
It is equally interesting that when DA was applied at concen-
trations greater than 30 mM, cAMP levels fell below the level
detected in TricaDop3-expressing cells prior to applying either
NKH-477 or DA (blanks, Fig. 8). At the highest DA concentrations
tested, cAMP levels were reduced to minimum levels regardless of
the concentration of receptor construct used for the transfection
(Fig. 11).
Further phylogenetic and pharmacological studies will be
needed to further clarify how the different metazoan biogenic
amine receptors are related to each other and how they can be
pharmacologically distinguished from one another. This informa-
tion will enable functional experiments to be undertaken with
drugs that show receptoreselective activity, which may lead to the
development of a novel generation of insect pest control agents
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